IL290951A - Prediction of cardiovascular risk events and their use - Google Patents
Prediction of cardiovascular risk events and their useInfo
- Publication number
- IL290951A IL290951A IL290951A IL29095122A IL290951A IL 290951 A IL290951 A IL 290951A IL 290951 A IL290951 A IL 290951A IL 29095122 A IL29095122 A IL 29095122A IL 290951 A IL290951 A IL 290951A
- Authority
- IL
- Israel
- Prior art keywords
- cardiovascular risk
- risk event
- event prediction
- prediction
- cardiovascular
- Prior art date
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962895383P | 2019-09-03 | 2019-09-03 | |
| PCT/US2020/048981 WO2021046074A1 (en) | 2019-09-03 | 2020-09-02 | Cardiovascular risk event prediction and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL290951A true IL290951A (en) | 2022-04-01 |
Family
ID=72521733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL290951A IL290951A (en) | 2019-09-03 | 2022-02-27 | Prediction of cardiovascular risk events and their use |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220349904A1 (https=) |
| EP (1) | EP4025916A1 (https=) |
| JP (2) | JP7712913B2 (https=) |
| KR (1) | KR20220057534A (https=) |
| CN (1) | CN114641692B (https=) |
| AU (1) | AU2020343243A1 (https=) |
| BR (1) | BR112022003666A2 (https=) |
| CA (1) | CA3151482A1 (https=) |
| IL (1) | IL290951A (https=) |
| MX (1) | MX2022002314A (https=) |
| WO (1) | WO2021046074A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025173327A1 (ja) * | 2024-02-14 | 2025-08-21 | Ｎｅｃソリューションイノベータ株式会社 | 罹患死亡可能性予測モデル、罹患死亡可能性予測方法、罹患死亡可能性予測装置、プログラム、及び記録媒体 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001577A (en) | 1998-06-08 | 1999-12-14 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
| US5705337A (en) | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
| US5660985A (en) | 1990-06-11 | 1997-08-26 | Nexstar Pharmaceuticals, Inc. | High affinity nucleic acid ligands containing modified nucleotides |
| US5763177A (en) | 1990-06-11 | 1998-06-09 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
| EP0786469B1 (en) | 1990-06-11 | 2006-03-01 | Gilead Sciences, Inc. | Methods of use of nucleic acid ligands |
| US5580737A (en) | 1990-06-11 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | High-affinity nucleic acid ligands that discriminate between theophylline and caffeine |
| US6458539B1 (en) | 1993-09-17 | 2002-10-01 | Somalogic, Inc. | Photoselection of nucleic acid ligands |
| US6242246B1 (en) | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
| WO2008056034A1 (en) * | 2006-11-10 | 2008-05-15 | Hytest Ltd. | Stable standards for bnp immunoassays |
| EP2302395B1 (en) * | 2006-06-07 | 2015-04-15 | Health Diagnostic Laboratory, Inc. | Markers associated with arteriovascular events and methods of use thereof |
| US7855054B2 (en) | 2007-01-16 | 2010-12-21 | Somalogic, Inc. | Multiplexed analyses of test samples |
| US7947447B2 (en) | 2007-01-16 | 2011-05-24 | Somalogic, Inc. | Method for generating aptamers with improved off-rates |
| DK2172566T4 (da) | 2007-07-17 | 2022-06-13 | Somalogic Inc | Fremgangsmåde til generering af aptamerer med forbedrede off-rates |
| WO2012006632A2 (en) | 2010-07-09 | 2012-01-12 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
| KR20120101064A (ko) * | 2009-11-13 | 2012-09-12 | 비쥐 메디신, 인코포레이티드 | 심근 경색의 위험 인자 및 예측 |
| EP2593566B1 (en) * | 2010-07-14 | 2018-01-24 | The Regents of The University of California | Biomarkers for diagnosis of transient ischemic attacks |
| CN103429753A (zh) | 2010-09-27 | 2013-12-04 | 私募蛋白质体公司 | 间皮瘤生物标记及其用途 |
| MX373248B (es) * | 2011-09-30 | 2020-05-11 | Somalogic Operating Co Inc | Prediccion de riesgo de evento cardiovascular y usos del mismo. |
| EP2835641A1 (en) * | 2013-08-09 | 2015-02-11 | Inotrem | Methods and kits for predicting the risk of having a cardiovascular disease or event |
| ES2792227T3 (es) * | 2014-09-26 | 2020-11-10 | Somalogic Inc | Predicción de evento de riesgo cardiovascular y usos de la misma |
| CN108291330A (zh) * | 2015-07-10 | 2018-07-17 | 西弗吉尼亚大学 | 卒中和卒中严重性的标志物 |
-
2020
- 2020-09-02 AU AU2020343243A patent/AU2020343243A1/en active Pending
- 2020-09-02 WO PCT/US2020/048981 patent/WO2021046074A1/en not_active Ceased
- 2020-09-02 MX MX2022002314A patent/MX2022002314A/es unknown
- 2020-09-02 CN CN202080060080.3A patent/CN114641692B/zh active Active
- 2020-09-02 KR KR1020227006316A patent/KR20220057534A/ko active Pending
- 2020-09-02 CA CA3151482A patent/CA3151482A1/en active Pending
- 2020-09-02 JP JP2022513923A patent/JP7712913B2/ja active Active
- 2020-09-02 EP EP20772497.2A patent/EP4025916A1/en active Pending
- 2020-09-02 BR BR112022003666A patent/BR112022003666A2/pt unknown
- 2020-09-02 US US17/637,128 patent/US20220349904A1/en active Pending
-
2022
- 2022-02-27 IL IL290951A patent/IL290951A/en unknown
-
2025
- 2025-04-28 JP JP2025073876A patent/JP2025118715A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025118715A (ja) | 2025-08-13 |
| JP2022546515A (ja) | 2022-11-04 |
| CN114641692A (zh) | 2022-06-17 |
| US20220349904A1 (en) | 2022-11-03 |
| CN114641692B (zh) | 2025-09-16 |
| MX2022002314A (es) | 2022-06-02 |
| AU2020343243A1 (en) | 2022-03-10 |
| CA3151482A1 (en) | 2021-03-11 |
| JP7712913B2 (ja) | 2025-07-24 |
| WO2021046074A1 (en) | 2021-03-11 |
| EP4025916A1 (en) | 2022-07-13 |
| KR20220057534A (ko) | 2022-05-09 |
| BR112022003666A2 (pt) | 2022-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL294052B2 (en) | Fluoroalkyl oxadiazoles and their uses | |
| ZA201908301B (en) | Biomarkers and uses thereof | |
| IL285177A (en) | compounds and their use | |
| ZA202105643B (en) | Processes and compounds | |
| IL267925B (en) | hsd17b13 variants and their uses | |
| GB201810897D0 (en) | Phenotype prediction | |
| IL286497A (en) | compounds and their use | |
| HUE065914T2 (hu) | Futófelület összeállítás és futópad | |
| ZA202203618B (en) | Mmup monomer variant and application thereof | |
| IL291499A (en) | Azaquinoline compounds and their uses | |
| HUE065964T2 (hu) | Futófelület összállítás és futópad | |
| ZA202105752B (en) | Haloallylamine compounds and application thereof | |
| SG11202108079RA (en) | Compounds and uses thereof | |
| ZA202203568B (en) | Mnep monomer variant and application thereof | |
| IL287503A (en) | Thio-semicarbazide compounds and their use | |
| IL284764A (en) | compounds and their uses | |
| GB201812561D0 (en) | Biomarkers and uses thereof | |
| GB201806042D0 (en) | Biomarkers and uses thereof | |
| GB201900253D0 (en) | Catalysts and uses thereof | |
| GB201902449D0 (en) | Range prediction | |
| IL290951A (en) | Prediction of cardiovascular risk events and their use | |
| IL288828A (en) | Binding factors - cd38 and their use | |
| EP4051850C0 (en) | SCAFFOLDING AND ITS INTERMEDIATE ELEMENT | |
| IL273671A (en) | Cornoline variants and their use | |
| ZA202201239B (en) | Aminothiolester compounds and uses thereof |